Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Rhea-AI Summary

Organogenesis Holdings (Nasdaq: ORGO), a leading regenerative medicine company, has announced its participation in two upcoming investor conferences in September 2024. The company will attend:

1. The Morgan Stanley Global Healthcare Conference in New York, NY, where management will participate in investor 1x1 meetings without a formal presentation.

2. The Cantor Fitzgerald Global Healthcare Conference in New York, NY, featuring a fireside chat on September 18 at 1:20 p.m. Eastern Time. This presentation will be webcast and accessible via the company's website, with a replay available for approximately 30 days.

These conferences provide Organogenesis an opportunity to showcase its focus on developing, manufacturing, and commercializing product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

News Market Reaction

-2.22%

1 alert

-2.22% News Effect

On the day this news was published, ORGO declined 2.22%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CANTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the following upcoming investor conferences:

The Morgan Stanley Global Healthcare Conference at the New York Marriott Marquis in New York, NY

• Management will participate in investor 1x1 meetings. There will be no formal presentation.
  

The Cantor Fitzgerald Global Healthcare Conference at the InterContinental Barclay Hotel in New York, NY

• Management will participate in a fireside chat on Wednesday, September 18 at 1:20 p.m. Eastern Time.
  

A webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www.organogenesis.com. An archive of the webcast will be available for replay following the conference for approximately 30 days.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com

FAQ

Which investor conferences will Organogenesis Holdings (ORGO) attend in September 2024?

Organogenesis Holdings (ORGO) will attend the Morgan Stanley Global Healthcare Conference and the Cantor Fitzgerald Global Healthcare Conference in September 2024, both in New York, NY.

When is Organogenesis Holdings' (ORGO) fireside chat at the Cantor Fitzgerald Global Healthcare Conference?

Organogenesis Holdings' (ORGO) fireside chat at the Cantor Fitzgerald Global Healthcare Conference is scheduled for Wednesday, September 18, 2024, at 1:20 p.m. Eastern Time.

Will there be a webcast of Organogenesis Holdings' (ORGO) presentation at the Cantor Fitzgerald conference?

Yes, a webcast of Organogenesis Holdings' (ORGO) presentation at the Cantor Fitzgerald conference will be available on the company's website in the 'Upcoming Events' section of the 'Investor Relations' page.

How long will the replay of Organogenesis Holdings' (ORGO) Cantor Fitzgerald conference presentation be available?

The replay of Organogenesis Holdings' (ORGO) Cantor Fitzgerald conference presentation will be available for approximately 30 days following the conference.

What markets does Organogenesis Holdings (ORGO) focus on?

Organogenesis Holdings (ORGO) focuses on developing, manufacturing, and commercializing product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.